Home » Topics » BioWorld Science

BioWorld Science
RSS

Biogen synthesizes new IRAK-4 inhibitors

Aug. 5, 2020

Minghui Pharmaceutical presents new BTK inhibitors

Aug. 5, 2020

Chinese investigators patent IDO1 inhibitors

Aug. 5, 2020

Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs

Aug. 5, 2020

Phase II trial of EPX-100 underway in children with Dravet syndrome

Aug. 5, 2020

IL12-L19L19 trial underway in advanced solid carcinomas and DLBCL

Aug. 5, 2020

AC Immune to advance anti-TDP-43 antibody toward clinical development

Aug. 5, 2020

Picturing molecular alterations

Aug. 5, 2020

FDA issues complete response letter for Viaskin Peanut

Aug. 4, 2020

Phase II study evaluates BMS-986278 in lung fibrosis

Aug. 4, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...